HLB Therapeutics Market Cap

HLB Therapeutics has a market cap or net worth of 264.89 billion as of January 16, 2026. Its market cap has decreased by -69.58% in one year.

Market Cap

264.89B

Enterprise Value

283.62B

Revenue

63.25B

Ranking

n/a

PE Ratio

n/a

Stock Price

3,215.00

Market Cap Chart

Since March 26, 2010, HLB Therapeutics's market cap has increased from 105.80B to 264.89B, an increase of 150.35%. That is a compound annual growth rate of 5.97%.

Market Cap History

Date	Market Cap	% Change
Jan 19, 2026	264.89B	5.17%
Dec 30, 2025	251.87B	-73.05%
Dec 30, 2024	934.49B	182.02%
Dec 28, 2023	331.36B	-9.25%
Dec 29, 2022	365.14B	-3.64%
Dec 30, 2021	378.91B	-51.22%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	90.13T
Celltrion	45.73T
ALTEOGEN	27.70T
ABL Bio	10.89T
SK Biopharmaceuticals	9.43T
Yuhan	8.05T
HLB Co., Ltd.	6.97T
Sam Chun Dang Pharm.	6.49T

Market Cap Rankings